Disposition of 440 shares by Seana Carson of Bausch Health at 8.35 subject to Rule 16b-3
BHC Stock | USD 8.12 0.01 0.12% |
About 55% of Bausch Health's investor base is interested to short. The analysis of overall sentiment of trading Bausch Health Companies stock suggests that many investors are impartial at this time. The current market sentiment, together with Bausch Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Bausch Health Companies stock news signals to limit their universe of possible portfolio assets.
Bausch |
Filed transaction by Bausch Health Companies Officer: Evp, General Counsel. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at seekingalpha.com
Bausch Health Fundamental Analysis
We analyze Bausch Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Bausch Health is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Bausch Health Companies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bausch Health stock to make a market-neutral strategy. Peer analysis of Bausch Health could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics with similar companies.
Peers
Bausch Health Related Equities
NBIX | Neurocrine Biosciences | 1.36 | ||||
ZTS | Zoetis | 0.97 | ||||
CTLT | Catalent | 0.47 | ||||
TAK | Takeda Pharmaceutical | 0.51 | ||||
LFCR | Lifecore Biomedical | 0.56 | ||||
HLN | Haleon Plc | 0.62 | ||||
VTRS | Viatris | 1.15 | ||||
EBS | Emergent Biosolutions | 1.53 | ||||
TLRY | Tilray | 1.54 | ||||
TEVA | Teva Pharma | 2.75 | ||||
SHPH | Shuttle Pharmaceuticals | 6.25 |
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |